Memic Innovative Surgery Welcomes Robert L. Ryan and Sandra Morgan...

Memic Innovative Surgery Welcomes Robert L. Ryan and Sandra Morgan to the Board of Directors

Healthcare Tech Outlook | Tuesday, September 21, 2021

Robert L. Ryan and Sandra Morgan have agreed to join the board of directors of Memic Innovative Surgery Ltd.

FREMONT, CA: Robert L. Ryan and Sandra Morgan have agreed to join the board of directors of Memic Innovative Surgery Ltd., a medical device business dedicated to changing surgery with its proprietary surgical robotic technology. Ryan and Morgan, who formerly worked in leadership roles at Medtronic and HCA, will join the board of directors pending completing the business combination agreement between Memic and MedTech Acquisition Corporation, which is expected to occur in Q4 2021.

"We are very pleased to welcome Bob and Sandra to our board during an important time in Memic's evolution as we plan for many important milestones and expand the commercial opportunities with our Hominis® platform, a technology that has the potential to transform the way surgeons perform robot-assisted procedures," said Dvir Cohen, Co-founder and Chief Executive Officer of Memic. "Bob is a recognized senior executive with extensive experience in building technology businesses. We believe his operational and financial experience, including serving as CFO at Medtronic, will be a vital asset as we plan for continued growth in our global operations in the years ahead. Sandra's accomplishments in the healthcare industry span over three decades, including 13 years at HCA. We believe her extensive experience working with hospitals, healthcare providers and payors will be instrumental as we work to build many new relationships with leading surgeons who can benefit from our technology."

"This is a transformational time for Memic, following the recently announced business combination agreement with MedTech Acquisition Corporation last month and the continuing growth in commercial opportunities for the company," said Mr. Ryan. "I am excited to join the board upon the closing of the business combination with MedTech. We look forward to developing and executing strategic plans that will optimize the commercial opportunities for the Hominis system and bring this innovative technology to leading hospitals and other medical facilities in the United States and around the world."

Mr. Ryan has worked in senior positions in strategic planning and business development at many significant international corporations. In 2005, he stepped down from his position at Medtronic. Ryan led Medtronic's finance responsibilities, such as treasury, tax, controllership, internal audit, and investor relations, for over 12 years, during which the firm saw significant global growth. He worked with Citibank from 1975 to 1982, including five years as the chief of the media lending department.

"I am delighted to join the board of directors upon the closing of the business combination with MedTech as Memic plans for continued global commercial opportunities for the disruptive Hominis platform," said Ms. Morgan. "I look forward to contributing to Memic's future growth and success building on the company's first FDA-authorized indication of Hominis in women's health including benign hysterectomy via the transvaginal approach. This technology has the potential to change patients' lives."

Ms. Morgan has 32 years of expertise in healthcare and executive leadership with Fortune 100 businesses. She most recently worked at HCA Healthcare as a senior vice president of provider relations. Her commitments at HCA included business growth for hospitals, ambulatory surgery centers, urgent care clinics, transfer centers, and all service lines, such as surgical and robotics, women's and children's, neurology, oncology, emergency services, behavioral health, employer brokers, and rural markets, throughout her 13-year tenure.

Weekly Brief